
    
      This is a Phase 1 study in healthy volunteers to evaluate the potential effect of multiple
      doses of paroxetine on the pharmacokinetics and safety of HBI-3000. Each subject serves as
      his/her own control: Period 1 vs. Period 2.
    
  